August 21, 2015 | By: Calevir
In the world of risk mitigation, it’s not often that there’s a straightforward solution. So, when there is, it’s worth some serious consideration. In the case of error-prone medication dosage abbreviations, it’s as easy as this: don’t use them (available to the public for a limited time). Use of medication dosage abbreviations is a long standing, well known patient safety risk, but errors continue to occur. Some solutions have been shared by the ISMP (list of error-prone, abbreviations symbols and dose designations), NCCMERP, USP and TJC (Do Not Use List) as well as ECRI. One solution is to effectively use CPOE to avoid use of risky abbreviations and other prevention strategies such as avoiding print materials with abbreviations, use of reminder cards, laminates, posters, etc.
A recent Pennsylvania case shows how courts narrowly interpret the PSQIA, ignoring the D & A pathway and the clear language of the Final Rule. (Ungurian v. Beyzman, et al., 2020 PA Super 105). The cour
The Center for Patient Safety wants to share this important harm-prevention advice from The Joint Commission and its Sentinel Event Alert: Managing the Risks of Direct Oral Anticoagulants. The Joint Commis
Issue: A number of events reported co CPS’ Patient Safety Organization (PSO) demonstrate poor handoff communication about the patients’ infectious disease status Examples include: Patient with
The Center for Patient Safety believes that collaboration and sharing are the best ways to drive improvement. We strive to provide the right solutions and resources to improve healthcare safety and quality.